Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Modeling Therapy Resistance in BRCA1/2-Mutant Cancers.

Dréan A, Williamson CT, Brough R, Brandsma I, Menon M, Konde A, Garcia-Murillas I, Pemberton HN, Frankum J, Rafiq R, Badham N, Campbell J, Gulati A, Turner NC, Pettitt SJ, Ashworth A, Lord CJ.

Mol Cancer Ther. 2017 Sep;16(9):2022-2034. doi: 10.1158/1535-7163.MCT-17-0098. Epub 2017 Jun 15.

2.

ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.

Williamson CT, Miller R, Pemberton HN, Jones SE, Campbell J, Konde A, Badham N, Rafiq R, Brough R, Gulati A, Ryan CJ, Francis J, Vermulen PB, Reynolds AR, Reaper PM, Pollard JR, Ashworth A, Lord CJ.

Nat Commun. 2016 Dec 13;7:13837. doi: 10.1038/ncomms13837.

3.

Rearrangement of epoxynitriles: a convenient homologation of acyclic and cyclic ketones to carboxylic acids.

Badham NF, Mendelson WL, Allen A, Diederich AM, Eggleston DS, Filan JJ, Freyer AJ, Killmer LB Jr, Kowalski CJ, Liu L, Novack VJ, Vogt FG, Webb KS, Yang J.

J Org Chem. 2002 Jul 26;67(15):5440-3.

PMID:
12126449
4.
5.
6.

An unusual legionellosis case yields the first New Zealand isolation of Legionella dumoffii.

Badham NR, Chereshsky AY, Pearce JL, Metcalfe RV, Bettelheim KA, Edelstein PH.

N Z Med J. 1985 Mar 27;98(775):204. No abstract available.

PMID:
3856769
7.

Blood blisters and the oesophageal cast.

Badham NJ.

J Laryngol Otol. 1967 Jul;81(7):791-803. No abstract available.

PMID:
6029172

Supplemental Content

Loading ...
Support Center